PeptideDB

Lorglumide sodium salt 1021868-76-7

Lorglumide sodium salt 1021868-76-7

CAS No.: 1021868-76-7

Lorglumide sodium salt (CR-1409 sodium salt) is a potent cholecystokinin (CCK) receptor blocker (antagonist).
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Lorglumide sodium salt (CR-1409 sodium salt) is a potent cholecystokinin (CCK) receptor blocker (antagonist).

Physicochemical Properties


Molecular Formula C22H31CL2N2NAO4
Molecular Weight 481.3883
Exact Mass 480.155
CAS # 1021868-76-7
PubChem CID 23681233
Appearance White to off-white solid powder
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 14
Heavy Atom Count 31
Complexity 544
Defined Atom Stereocenter Count 0
InChi Key JCNPYMDDOUQTBK-UHFFFAOYSA-M
InChi Code

InChI=1S/C22H32Cl2N2O4.Na/c1-3-5-7-13-26(14-8-6-4-2)22(30)19(11-12-20(27)28)25-21(29)16-9-10-17(23)18(24)15-16;/h9-10,15,19H,3-8,11-14H2,1-2H3,(H,25,29)(H,27,28);/q;+1/p-1
Chemical Name

sodium;4-[(3,4-dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxopentanoate
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat. Br J Pharmacol. 1989 Mar;96(3):661-9.


Solubility Data


Solubility (In Vitro) DMSO : ~100 mg/mL (~207.73 mM)
H2O : ≥ 100 mg/mL (~207.73 mM)
Solubility (In Vivo) Solubility in Formulation 1: 2.08 mg/mL (4.32 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (4.32 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

Solubility in Formulation 3: 50 mg/mL (103.87 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with ultrasonication.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.0773 mL 10.3866 mL 20.7732 mL
5 mM 0.4155 mL 2.0773 mL 4.1546 mL
10 mM 0.2077 mL 1.0387 mL 2.0773 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.